UroGen Pharma Ltd. (LS:A2DTCV) IPO

UroGen Pharma Ltd.

IPO

Priced at US$13.00 a share on May 3, 2017.

Price
US$13.00 a share
Shares offered
4,473,373 ordinary shares
Offering size
US$58.2 million
Underwriters' option
Up to 671,005 more shares
Underwriters
Jefferies, Cowen and Company, Raymond James, Oppenheimer & Co. · In the order on the cover
Shares delivered
On or about May 9, 2017

Steps

StepWhen
Draft sent to the SEC in confidenceMar 4, 2016
Filed publiclyApr 7, 2017
Amended onceApr 24, 2017
Shares registered with an exchangeMay 1, 2017
Declared effective by the SECMay 3, 2017
Final prospectus, with the priceMay 5, 2017

From the cover of the final prospectus (424B4) filed May 5, 2017